|
| Saturday, February 4, 2023 |
|
|
亚太地区细胞与基因研究：Novotech 的增长速度比世界其它地区快 50% |
| Novotech 是亚太地区领先的生物技术专家 CRO 和亚太地区细胞与基因治疗临床试验卓越奖的获得者，该公司表示该地区细胞与基因治疗试验的数量增长速度比世界其它地区快 50%。 大多数试验都在肿瘤学领域，特别是针对血癌、病毒感染和实体瘤。 more info >> |
|
|
亞太地區細胞與基因研究：Novotech 的增長速度比世界其它地區快 50% |
| Novotech 是亞太地區領先的生物技術專家 CRO 和亞太地區細胞與基因治療臨床試驗卓越獎的獲得者，該公司表示該地區細胞與基因治療試驗的數量增長速度比世界其它地區快 50%。大多數試驗都在腫瘤學領域，特別是針對血癌、病毒感染和實體瘤。 more info >> |
|
|
아시아 태평양 지역 세포유전자 연구: 노보텍이 세계의 나머지 모든 기관들보다 50% 더 빠르게 성장 |
| 아시아 태평양 지역의 선도적인 생명공학 전문 임상시험수탁기관(CRO)이며 아시아 태평양 지역 세포유전자 치료제 임상시험 우수상을 수상한 노보텍(Novotech)은 이 지역에서의 세포유전자 치료제 임상시험 수가 세계의 나머지(ROW) 모든 시험 수에 비해 50% 더 빠르게 성장하고 있다고 밝혔습니다. 대부분의 시험은 종양학, 특히 혈액암과 바이러스 감염, 고형 종양 등의 시험입니다. more info >> |
|
| Friday, February 3, 2023 |
|
|
Asia Pacific Cell & Gene Research Growing 50% Faster than ROW |
| Novotech, the leading Asia Pacific focused biotech specialist CRO and recipient of the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence award, said the number of cell & gene therapy trials in the region was growing 50% faster than ROW. The majority of trials are in oncology, specifically for blood cancers, viral infections, and solid tumors. more info >> |
|
| Thursday, January 12, 2023 |
|
|
Novotech Acquires US-based Drug Development Consulting Firm, CBR International |
| Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR International, a global product development, clinical oversight and strategic regulatory operations group. more info >> |
|
|
Novotech Acquires European CRO, Strengthens Global Operations |
| Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent. The acquisition is part of Novotech's global expansion program. EastHORN was established in 2004 and has over 250 employees. more info >> |
|
|
Novotech 收购美国药物开发咨询公司 CBR International |
| 太地区领先的生物技术 CRO Novotech 今天宣布收购全球产品开发、临床监督和战略监管运营集团 CBR International。 more info >> |
|
|
Novotech 收購美國藥物開發諮詢公司 CBR International |
| 太地區領先的生物技術 CRO Novotech 今天宣布收購全球產品開發、臨床監督和戰略監管運營集團 CBR International。 more info >> |
|
|
Novotech 收购欧洲 CRO——加强全球运营 |
| Novotech 今天宣布收购 EastHORN，这是一家欧洲 CRO，在欧洲大陆多个具有重要战略意义的地点拥有临床、医疗和监管专业知识。此次收购是 Novotech 全球扩张计划的一部分。 EastHORN 成立于 2004 年，拥有 250 多名员工。 more info >> |
|
|
Novotech 收購歐洲 CRO——加強全球運營 |
| Novotech 今天宣布收購 EastHORN，這是一家歐洲 CRO，在歐洲大陸多個具有重要戰略意義的地點擁有臨床、醫療和監管專業知識。此次收購是 Novotech 全球擴張計劃的一部分。 EastHORN 成立於 2004 年，擁有 250 多名員工。 more info >> |
|
|
|
|
